Antiangiogenic Agents After First Line and Sorafenib Plus Chemoembolization: A Systematic Review
Oncotarget - United States
doi 10.18632/oncotarget.19449
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 23, 2017
Authors
Publisher
Impact Journals, LLC